Baidu
map

Lancet:西京医院团队发现吲哚美辛栓剂应作为ERCP术前常规用药

2016-05-06 Mechront 译 MedSci原创

对经内镜逆行胰胆管造影术(ERCP)的人群,直肠予以吲哚美辛可减少胰腺炎发生风险,不过是应该在ERCP之前对所有患者予以吲哚美辛,还是之后对高危人群予以吲哚美辛呢?该多中心、单盲、随机对照试验在中国的6个中心进行。在2013-12-15到2015-9-21共有2600名患者参与研究,按1:1随机分为ERCP前所有人使用吲哚美辛(n=1297,ERCP前30分钟内直肠予以100mg吲哚美辛)和ERC

MedSci小编注:

现在还有一大批年青医生还在争论,要不要发表SCI文章,或者说SCI文章就是垃圾,或者说临床医生只要专心看好病就行了的时候。国内另外一批临床医生开始往国际顶尖领域冲刺了!昨天国内发了一篇NEJM(NEJM:他汀不能预防心脏手术后房颤(STICS研究)),今天一篇Lancet!相信未来,新英格兰,柳叶刀这些期刊上,有大量的中国学者的身影!

发表高水平研究论文不是目的,而在于这些成果将会被国际认可,甚至写入指南,推动医学领域真正的进步与发展!

如果你今天还在犹豫要不要发表论文时,你应该汗颜一阵子了。因为,此时还不想着着手开展临床研究,发表SCI文章的话,以后可能就彻底失去在学术的舞台上的机会!

正文:

对经内镜逆行胰胆管造影术(ERCP)的人群,直肠予以吲哚美辛可减少胰腺炎发生风险,不过是应该在ERCP之前对所有患者予以吲哚美辛,还是之后对高危人群予以吲哚美辛呢?

该多中心、单盲、随机对照试验在中国的6个中心进行。在2013-12-15到2015-9-21共有2600名患者参与研究,按1:1随机分为ERCP前所有人使用吲哚美辛(n=1297,ERCP前30分钟内直肠予以100mg吲哚美辛)和ERCP后高危人群使用吲哚美辛(n=1303,高危人群ERCP后立即予以100mg吲哚美辛)。以ERCP后两组胰腺炎发生情况为主要结局指标。

研究结果显示,EFCP前后给药的两组人群中操作后胰腺炎发生情况分别为47 (4%)名和100 (8%)名(RR=0.47; 95% CI 0.34–0.66; p<0.0001)。ERCP前后给药的两组人群进行危险分层,就高危人群而言,ERCP后胰腺炎的发生情况分别为18/305 (6%)名和35/281 (12%)名(p=0·0057)。对于一般风险人群,ERCP前给药组其胰腺炎发生率更低(3% [29/992] vs 6% [65/1022](p=0·0003))。除了胰腺炎之外的其他不良事件在ERCP前后给药组发生情况分别为41 (3%;2例严重不良事件)和48 (4%; 1例严重不良事件) 。最常见的不良事件是胆道感染(22 [2%] vs 33 [3%])和胃肠道出血 (13 [1%] vs ten [1%])。

研究结果表明,与ERCP操作后针对高危人群使用吲哚美辛相比,在ERCP操作前对所有人群使用吲哚美辛,不仅可以降低ERCP后胰腺炎风险,同时不会增加出血风险。所以在没有禁忌症的情况下,应该对所有进行ERCP的人群在操作前常规直肠予以吲哚美辛。

原始出处:

Hui Luo, Lina Zhao,et al.Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.The Lancet.Published online: April 28, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
    2016-11-22 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
    2016-05-06 I come

    正能量,好文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
    2016-05-06 I come

    正能量,好文章

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1654674, encodeId=a39516546e4f8, content=<a href='/topic/show?id=647390461ec' target=_blank style='color:#2F92EE;'>#西京医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90461, encryptionId=647390461ec, topicName=西京医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=506624510345, createdName=dongjia2018, createdTime=Sat Dec 03 06:19:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828467, encodeId=81d3182846eae, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Nov 22 03:19:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361357, encodeId=4543136135ec7, content=<a href='/topic/show?id=7a793932618' target=_blank style='color:#2F92EE;'>#吲哚美辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39326, encryptionId=7a793932618, topicName=吲哚美辛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 08 01:19:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84443, encodeId=90ca8444342, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:55:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84442, encodeId=cf78844426e, content=正能量,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK9CDibOwszLoEBg36ZXqzB5NDasNV9GTfFDmBicM1V8hUS4OtTicG3IiaFIKq4wqD23LUxORRJXqjVs/0, createdBy=00e81647535, createdName=I come, createdTime=Fri May 06 19:54:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84427, encodeId=1d568442e86, content=满满的正能量!每天来这里都收获满满!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 06 14:58:00 CST 2016, time=2016-05-06, status=1, ipAttribution=)]
    2016-05-06 lovetcm

    满满的正能量!每天来这里都收获满满!

    0

相关资讯

Gastroenterology:吲哚美辛能否预防ERCP后胰腺炎的发生?

经直肠给吲哚美辛(非甾体类抗炎药)常用于行内镜下逆行胰胆管造影(ERCP)的胰腺炎高危患者的预防。欧洲胃肠内镜协会指南推荐对所有行ERCP的患者使用吲哚美辛进行预防,包括胰腺炎普通风险的人群。因此研究者进行了一项研究,探讨这种方法的疗效。该随机双盲安慰剂对照试验纳入了449名行ERCP的患者,约有70%的患者是ERCP术后胰腺炎(PEP)一般风险患者,研究者将患者随机分为试验组(n=223,100

Gastrointest Endosc:经验丰富内镜医师行ERCP患者受辐射更小

患者在ERCP手术过程中暴露于电离辐射,这与X线平片和CT扫描一样,会增加终生患癌风险和引发其它不良的辐射后果。 终生患癌率风险值的评估基于辐射有效剂量。后者以希沃特(Sv)为单位,可用于不同放射手段间的对比。 一般一次普通的腹部CT辐射有效剂量有效剂量大约为10mSv,所带来的终生癌死亡率风险为1/2000。一次腹部X线平片和钡剂灌肠操作的辐射有效剂量分别为0.7 mSv和7 m

GASTROINTEST ENDOSC:新型ERCP生物训练模型有效实用

临床上传统训练ERCP的方式往往是导师带教在实践中练习,这不仅受到伦理牵制,更重要的是操作者的经验缺乏会导致医疗风险的增加,所以ERCP生物模型的制作在近十年受到越来越多的重视,而现有的许多模型存在造价昂贵或者依赖活体动物等弊端没有广泛普及。 Jacobo博士等墨西哥、美国和巴西的学者共同参与了一种新颖、简单的ERCP生物训练模型的制作和操作效果评估,文章近期发表在GASTROINTES

NEJM:直肠吲哚美辛可降低ERCP术后胰腺炎发病率

近日,新英格兰杂志(New England Journal of Medicine)发表的一项大型随机试验的结果表明,患者在内镜逆行胰胆管造影(ERCP)后接受直肠吲哚美辛的术后胰腺炎发生率显著较低。 ERCP术后给予单剂吲哚美辛与胰腺炎发病率减少了45%(包括较为稀少的中度或重度胰腺炎减少了50%)相关。吲哚美辛带来的益处与患者的风险类别相一致,尽管风险较高的患者受益的情况往往更多。 “我们

Baidu
map
Baidu
map
Baidu
map